<DOC>
	<DOCNO>NCT00453271</DOCNO>
	<brief_summary>The purpose study determine whether NB002 , 0.25 % , 0.5 % safe effective treatment distal subungual onychomycosis toenail .</brief_summary>
	<brief_title>Treatment Mild Moderate Distal Subungual Onychomycosis Toenail</brief_title>
	<detailed_description>The purpose study determine whether NB002 , 0.25 % , 0.5 % safe effective treatment distal subungual onychomycosis toenail .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<criteria>healthy male female age 18 75 year age ; clinical diagnosis mild moderate DSO nail least one great toe , involve 25 % 67 % nail , without lunular proximal involvement ; positive mycology result ( ie , KOH test culture dermatophyte ) target great toenail ; refrain use lotion , cream , liquid , polish treat toenail skin immediately adjacent toenail treatment period unless directed investigator ; willing refrain use topical steroid topical antifungal toenail skin immediately adjacent toenail ; systemic antifungal duration study ; female pregnant , plan become pregnant study , nurse child ; hypersensitive topical cream , ointment , medication , surfactant ; receive systemic antifungal therapy reason within 3 month , topical antifungal therapy toenail skin immediately adjacent toenail within 3 week prior start study ; take investigational drug within 4 week prior start study . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>chronic persistent infection nail bed plate</keyword>
</DOC>